Experimental cancer therapeutics delivered to tumors via nanoparticles could provide a safer and more effective therapy than conventional chemotherapy.
Advertisement
The Scientist
Most Recent
A new class of immune cell could protect against type 1 diabetes by suppressing other immune cells.
Emil Frei III, a cancer researcher who in the 1950s combined multiple chemotherapy drugs to treat childhood leukemia, has died at the age of 89.
The Bonobo and the Atheist, The Philadelphia Chromosome, Lone Survivors, and Paleofantasy
Research Associate, Perelman School of Medicine, University of Pennsylvania. Age: 27
University of Vermont neurologist Helene Langevin explains some emerging research attempting to explain the benefits of acupuncture.
Sorting out T-cell functional and phenotypic heterogeneity depends on studying single cells.
Viral infections of the central nervous system may trigger cytokines that induce seizures.
The study of connective tissue is shedding light on pain and providing new explanations for alternative medicine.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
